Package | hl7.fhir.us.icsr-ae-reporting |
Type | ValueSet |
Id | MedDRATransfusionAdverseEventVS |
FHIR Version | R4 |
Source | http://hl7.org/fhir/us/icsr-ae-reporting/https://build.fhir.org/ig/HL7/fhir-icsr-ae-reporting/ValueSet-MedDRATransfusionAdverseEventVS.html |
URL | http://hl7.org/fhir/us/icsr-ae-reporting/ValueSet/MedDRATransfusionAdverseEventVS |
Version | 1.0.1 |
Status | draft |
Date | 2023-08-30T17:02:44+00:00 |
Name | MedDRATransfusionAdverseEventVS |
Title | Transfusion-related Adverse Events |
Realm | us |
Authority | hl7 |
Description | MedDRA codes that represent the specific transfusion adverse events that are considered by this Implementation Guide |
Copyright | MedDRA® is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations. All rights reserved. |
StructureDefinition | |
transfusion-adverseevent | Transfusion Adverse Event |
No resources found
Note: links and images are rebased to the (stated) source
{ "resourceType": "ValueSet", "id": "MedDRATransfusionAdverseEventVS", "text": { "status": "additional", "div": "<!-- snip (see above) -->" }, "url": "http://hl7.org/fhir/us/icsr-ae-reporting/ValueSet/MedDRATransfusionAdverseEventVS", "version": "1.0.1", "name": "MedDRATransfusionAdverseEventVS", "title": "Transfusion-related Adverse Events", "status": "draft", "experimental": false, "date": "2023-08-30T17:02:44+00:00", "publisher": "Biomedical Research & Regulation WG", "contact": [ { "name": "Biomedical Research & Regulation WG", "telecom": [ { "system": "url", "value": "http://hl7.org/Special/committees/rcrim" } ] }, { "name": "Jean Duteau", "telecom": [ { "system": "email", "value": "mailto:jean.duteau@ibm.com" } ] } ], "description": "MedDRA codes that represent the specific transfusion adverse events that are considered by this Implementation Guide", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US", "display": "United States of America" } ] } ], "copyright": "MedDRA® is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations. All rights reserved." }